Solid tumor immunotherapy with T cell engager-armed oncolytic viruses
Oncolytic viruses (OVs) are novel anticancer agents that combine direct cancer cell killing with the stimulation of antitumor immunity. In addition, OVs can be engineered to deliver biological therapeutics directly to tumors, offering unique opportunities to design multimodal anticancer strategies....
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Wiley
2017
|